Jun 15, 2020
FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients
Jun 11, 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
May 27, 2020
Biotech Brief: Global Glioblastoma Multiforme Drug Market Could Exceed $1.4 Billion by 2025
Apr 28, 2020
Denovo Biopharma To Acquire Tocagen's Entire Replicating Gene Therapy Platform and Related Assets
Jan 29, 2020
DelMar Pharmaceuticals Announces Peer-Reviewed Publication of Interim Results of Phase 2 Clinical Trial of VAL-083 As First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma Multiforme
Nov 14, 2019
EMulate® Therapeutics Announces Multiple Presentations on the Voyager and Hælo® systems
Sep 12, 2019
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
Aug 28, 2019
EMulate Therapeutics® Submits Application for CE Mark
Jul 24, 2019
DelMar Pharmaceuticals Enrolls First Patient in the Recently-Approved Adjuvant Setting Arm of Phase 2 Study of VAL-083 for the Treatment of MGMT-Unmethylated Glioblastoma Multiforme
Jul 12, 2019
The Future of the Glioma Market in the United States 2019-2024: Treatment Options, Pipeline Products, Epidemiology, Key Products Marketed, Market Valuations & Forecast, Drugs Sales, and Market Shares
Jul 12, 2019
Global Brain Tumor Therapeutics Market Outlook Report, 2019-2024 - Immunotherapy Expected to Register Robust Growth
Jul 12, 2019
Global Adult Malignant Glioma Therapeutics Market Research Report 2019-2024: Merck & Co, Roche, and Pfizer Lead the Competition
Jun 03, 2019
DelMar Provides Clinical Update on VAL-083 from Ongoing First- and Second-Line Trials in Patients with MGMT-unmethylated Glioblastoma at a Key Opinion Leader Forum during the American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 03, 2019
Medicenna Presents Clinical Validation of the IL4 Receptor as a Biomarker for MDNA55 in Recurrent Glioblastoma
Mar 27, 2019
Tocagen to Present Updated Data from Clinical and Preclinical Studies at Two Scientific Conferences
Mar 12, 2019
xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
Feb 07, 2019
Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55
Jan 03, 2019
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Dec 04, 2018
A Moonshot for Kids: DIPG Awareness Resolution H.Res.69 Runs out of Time as Childhood Cancer Advocates Return to Capitol Hill
Nov 20, 2018
DelMar Presents Clinical Update on VAL-083 From Ongoing First- and Second-Line Trials in Patients with MGMT-unmethylated GBM at The Society for NeuroOncology Annual Meeting